17Early
Menten AI
Menten AI designs peptide and protein therapeutics using quantum…
UnfundedSan Francisco, CA, USA· drug discovery and delivery· Ranked #11 of 30 in drug discovery and deliveryWebsite
Score breakdown
Momentum35
Capital1
Traction10
Capital & traction
- Total raised
- —
- Last round
- —
- Round size
- —
- Round date
- —
- Valuation
- —
- Disclosed revenue
- —
Embed this score on your site
Copy the embed code
<a href="https://steek.live/companies/892"><img src="https://api.steek.live/scoreboard/company/892/badge.svg" alt="Steek Score" width="248" height="64" /></a>Competitors in drug discovery and delivery
| Company | Raised | Score |
|---|---|---|
| WhiteLab Genomics Unleashing the potential of DNA and RNA based therapies using AI | $23M | 57 |
| Numerion Labs Artificial intelligence for drug discovery. | — | 17 |
| Verge Genomics We use human data and AI to develop better drugs faster. | — | 17 |
| Helix Nanotechnologies Next-generation mRNA platform to solve cancer, COVID and climate. | — | 17 |
| Macromoltek Computational antibody design | — | 17 |
| Synkrino Biotherapeutics Synkrino's AI, SATIS is a powerful, unbiased discovery system for… | — | 17 |
| Arpeggio Bio Arpeggio Bio develops drugs targeting transcription factors using AI… | — | 17 |
| Abalone Bio We create activating antibodies to treat diseases others can’t. | — | 17 |
| Trident Bioscience Accelerating protein engineering. | — | 17 |
| PostEra Medicinal Chemistry powered by Machine Learning | — | 17 |
FAQs about Menten AI
What is Menten AI's Steek Score?
Menten AI has a Steek Score of 17 (Early) — a transparent 0–100 momentum index built from funding, traction and attention signals.
What sector is Menten AI in?
Menten AI operates in drug discovery and delivery, where it ranks #11 of 30 by Steek Score.
Who are Menten AI's competitors?
Top competitors include WhiteLab Genomics, Numerion Labs, Verge Genomics.
Where is Menten AI located?
Menten AI is based in San Francisco, CA, USA.
Steek Score is a transparent momentum index computed from tracked public signals. Not investment advice.